Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease

Acknowledging the limitations of our study, including publication and selection bias, rituximab had a favorable toxicity and efficacy profile. The results indicate that rituximab can be considered as a second-line therapy in anti-GBM disease when cyclophosphamide is contraindicated.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2024-12-31
DOI
https://doi.org/10.1016/j.ekir.2024.12.026
Citations
3
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
1.26
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease

Andreas Kronbichler, Annette Bruchfeld, Ajay Jaryal, Maxime Touzot et al.
3 citations
Kidney International Reports
Vasculitis and related conditions
1.26
article

Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease

Andreas Kronbichler, Annette Bruchfeld, Ajay Jaryal, Maxime Touzot, Mårten Segelmark, Georgina Maalouf, Richard Klaus, Dieter Haffner, Sanjay Vikrant, Stephen P. McAdoo, Bärbel Lange-Sperandio, Ingeborg M. Bajema, David Saadoun, Nele Kanzelmeyer, Vanja Ivković, Asheesh Kumar
article en
3 citations

Abstract

Acknowledging the limitations of our study, including publication and selection bias, rituximab had a favorable toxicity and efficacy profile. The results indicate that rituximab can be considered as a second-line therapy in anti-GBM disease when cyclophosphamide is contraindicated.

Kidney International ReportsVol. 10(3)
Linköping University (SE), University Medical Center Groningen (NL), Karolinska University Hospital (SE), Innsbruck Medical University (AT), Imperial College Healthcare NHS Trust (GB), University of Rijeka (HR), Inserm (FR), Lund University (SE), Hammersmith Hospital (GB), LMU Klinikum (DE), Medizinische Hochschule Hannover (DE), Sorbonne Université (FR), Centre de Référence des Maladies Autoinflammatoires et des Amyloses (FR), Skåne University Hospital (SE), Association pour l'Utilisation du Rein Artificiel (FR), Immunologie - Immunopathologie - Immunothérapie (FR), Imperial College London (GB), All India Institute of Medical Sciences (IN), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 17%
Vasculitis and related conditions
1.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.